Source: ERS Course 2021 - COVID-19: State of the art



Rating:

Share or cite this content

Citations should be made in the following way:
S. Williams (Limerick, Ireland), R. van der Made (Doorn, Netherlands). Patient view on COVID-19: Vaccines. ERS Course 2021 - COVID-19: State of the art

Member's Comments

No comment yet.

Related content which might interest you: Patient view Source: Eur Respir Monogr 2019; 85: 1-5 Year: 2019 Patient view: Long COVID Source: ERS Course 2021 - COVID-19: State of the art Year: 2021 Patient view: Acute COVID-19 experiences Source: ERS Course 2021 - COVID-19: State of the art Year: 2021 Patient view on COVID-19: Positive outcomes Source: ERS Course 2021 - COVID-19: State of the art Year: 2021 Patient's view Source: Virtual Congress 2021 – Highlights on gender and respiratory health Year: 2021 Patient perspective: video Source: Virtual Congress 2020 – Fear and anxiety, psychological wellbeing and prevention of psychological distress in chronic lung diseases Year: 2020 Patient perspective: video Source: Virtual Congress 2020 – Antibiotic resistance: the way forward Year: 2020 Late Breaking Abstract - Patient Reported Outcomes (PRO) Correlate Better with Intra-Breath than with Whole-Breath FOT Parameters. Source: International Congress 2017 – Late-breaking findings in asthma and COPD Year: 2017 Patient’s perspective Source: Virtual Congress 2021 – Precision medicine in asthma and COPD Year: 2021 Patient perspective Source: International Congress 2019 – Lung transplantation in 2019: where are we? Year: 2019 Patient perspective Source: International Congress 2019 – The added value of allied healthcare professionals in integrated respiratory care Year: 2019 Patient perspective Source: Virtual Congress 2020 – Improving the delivery of tobacco-use treatment Year: 2020 Problems of Importance in Severe Asthma: A Patient Perspective Source: International Congress 2019 – Person-centred approaches to COPD and asthma care Year: 2019 Late Breaking Abstract - Characteristics of Patients Diagnosed with Severe Asthma at UK Specialist Centres: Variation by Ethnicity Source: International Congress 2019 – Bronchiectasis Year: 2019 Book review: Asthma - Clinician’s Desk Reference Source: Eur Respir Rev 2012; 21: 170 Year: 2012 Late Breaking Abstract - Real-World Characteristics of Patients Receiving Dupilumab in Routine Clinical Practice in a Multinational, Non-Interventional Study (ProVENT) Source: Virtual Congress 2021 – Airway pharmacology: translational and basic science Year: 2021 Late Breaking Abstract - Standard-of-Care Asthma Controller Regimen Reduction with Benralizumab Treatment: ANDHI In Practice Study Source: Virtual Congress 2021 – Severe asthma: evaluation using patient-reported outcome measures (PROMs) and biomarkers, comorbidities and treatments Year: 2021